b'High-parameter spatial and multi-omic technologiesStandard BioTools provides a comprehensive suite of complementary high-integrity proteomics and genomics solutions to drive translational and clinical research insights.Breakthrough science Established organization Presence in250 7,800 $106M 4 top 10 71%clinical trials 1 publications 1 2023 revenue manufacturing sites pharma Comprehensive (worldwide) Cancer Centers (US)Proprietary technologies Global reach 1As of February 20241,600 800 1,500 45issued or catalog antibodies customers countriespending patents 1Proven technology for translational and clinical research Flow cytometryCyTOF technology is used for a broad range of applications to investigate the immune response to disease progression and pathways for the development of new therapies. Scientists have relied on SomaScan in 800-plus peer-reviewed publications, 1,000-plus issued and pending patents and 3-plus billion proteomic measurements and counting.Standard BioTools publications SomaScan publications 2,000 out of 2,077publications (96%) useStandard BioTools solutions.Tissue imaging200 out of 224 publications (89%) use Standard BioTools solutions.Data as of 202220-marker-panel high-parameter publications'